(Total Views: 426)
Posted On: 07/28/2020 10:11:23 AM
Post# of 208
Therapeutic Solutions International Files Patent on Ability of QuadraMune Ingredient Pterostilbene to Reduce Inflammation while Stimulating Brain Protective Biological Pathways
Mechanistic Studies Continuing on QuadraMune™ a COVID19 Candidate in Clinical Trial
Company Continues Quest to Dominate Intellectual Property Regarding COVID-19 Associated Pathologies
https://www.prnewswire.com/news-releases/ther...01258.html
Mechanistic Studies Continuing on QuadraMune™ a COVID19 Candidate in Clinical Trial
Company Continues Quest to Dominate Intellectual Property Regarding COVID-19 Associated Pathologies
https://www.prnewswire.com/news-releases/ther...01258.html
(0)
(0)Scroll down for more posts ▼
